PlainPill

Follistatin

People mainly take Follistatin for longevity. Based on 3 first-hand reports and 13 meta-analyses & systematic reviews in the medical literature. Ranked #1572 of 1,974 overall.

6
User score
Mostly negative
0% positive0% mixed33% negative67% unclear

Of reports that state an outcome, 0% are positive.

Clinical research
AStrong research base
13
meta-analyses
65
RCTs
2,968
papers
High-risk compound. Peptides are not approved as supplements, carry serious and sometimes irreversible risks, are banned in competitive sport and may be restricted where you live. Nothing here is a recommendation to use it.

What Follistatin does, according to users

Of the people who reported each effect, the share who said it got better.

betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

BMC Med Genomics · 2021 · Meta-analysis / systematic review
Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis

Conclusion: This systematic review and meta-analysis suggest that genes influencing inflammatory responses, specifically TNF, and genes influencing the function and activity of sebaceous glands, specifically CYP17A1 and FST, have potential risk variants for acne presentation and severity across populations. Understanding the genetic susceptibility factors and biological pathways involved in the pathogenesis of acne will help us to gain insights into developing effective acne treatments.

PubMed 33849530 ↗
Curr Cardiol Rev · 2024 · Meta-analysis / systematic review
The Association between Serum Follistatin-like Proteins and Cardiovascular Diseases: A Systematic Review and Meta-analysis

Conclusion: Our findings demonstrate significantly higher levels of FSTL1 in patients with CVD compared to control subjects. This suggests that FSTL1 may have potential as a diagnostic and prognostic biomarker in CVDs. However, further well-designed studies are needed to validate its clinical utility.

PubMed 39034719 ↗
PLoS One · 2021 · Meta-analysis / systematic review
Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis

Conclusion: Significant heterogeneity and publication bias was evident for some analyses. Circulating levels of resistin and follistatin, independent of obesity status, are higher in women with PCOS compared with controls, showing that these adipokines may contribute to the pathology of PCOS.

PubMed 33740002 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

No doses stated in the reports so far.

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“I also wouldn’t have a clue but look into follistatin”
Source discussion ↗
“I don't think it would be as strong as something like follistatin”
Source discussion ↗
“Follistatin (myostatin inhibition, muscle growth)”
Source discussion ↗
Top discussions (3)

Other options for longevity

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate